120
Participants
Start Date
May 13, 2024
Primary Completion Date
December 31, 2027
Study Completion Date
November 30, 2028
Tocilizumab treatment
"* 1 injection/2 weeks from W0 to W12: W0, W2, W4, W6, W8, W10, W12~* Then 1 injection/4 weeks until W24: W16, W20, W24"
questionnaires
HAQ, SF-36, FACIT-Fatigue score
Blood samples
Additionnal blood samples for immunomonitoring
18FDG PET scan
PETVAS calculation (to be performed between W0 and W8) (optional).
RECRUITING
Chu Dijon Bourgogne, Dijon
Centre Hospitalier Universitaire Dijon
OTHER